Diagnostic Reading #52: Five “Must Read” Articles on HIT and Radiology
Reading Time: 4 minutes read
5G in personalized care, patient use of medical devices, and PET applications in Alzheimer’s study are in this week’s news.
This week’s articles in Diagnostic Reading include: patients want improved access to images and radiology reports; QA software may play a role in what rads can and cannot say in their reports; the FDA released its first report on patient-reported outcomes from the use of medical devices; PET tracer florbetapir shows promise in a preclinical Alzheimer’s study; and 5G networks could expedite ability to provide personalized care.
RSNA 2017: Patients want improved access to images, reports – Radiology Business
Radiologists are no longer only the diagnostician’s doctor. With increased transparency in healthcare, patients are provided greater access to their radiology reports and are taking an active role in their health. An article published in JACR reports that 64 percent of patients wanted copies of their radiology reports and 85 percent wanted to see the images. Most patients also desire a detailed explanation of the reports in writing and the option of accessing the full report. Read the related blog on Four Reasons Why Medical Images Must Be Included in Patient Portals.
Things you can’t say…if you care about QA – Diagnostic Imaging
This blog spotlights the need for radiologists to think carefully about what they include in their report, thanks in part to QA software. Examples of pitfalls to avoid include: diagnosing ileus without mentioning bowel obstruction, calling a pediatric chest x-ray ‘normal’; and denying the existence of a pulmonary embolism.
FDA releases report on patient-reported outcomes – AuntMinnie
The FDA released its first report on patient-reported outcomes (PROs) from the use of medical devices. This data can include information such as how a patient functions with a new orthopaedic device, how a device affects a patient’s quality of life, or whether a device affects a patient’s symptoms. The FDA has seen the amount of PRO data it receives increase significantly in recent years; in 2017, more than 80% of investigational device exemptions included patient outcomes data.
A preclinical study from Belgium has shown promising results with the PET tracer florbetapir for targeting amyloid plaque and tau tangles in the brain and potentially evaluating the efficacy of certain Alzheimer’s treatments, according to an article in the Journal of Nuclear Medicine. This study demonstrated that accurate quantification of beta-amyloid tracers is critically important and that the nonspecific uptake in the brain of subjects might be underestimated for some existing Alzheimer’s tracers that have fast metabolization profiles, according to the authors.
Five ways 5G could fast-forward personalized care – HealthTech Magazine
Adoption of 5G networks in healthcare organizations and hospitals could have sweeping implications for health IT, enabling more than $1 trillion in products and services for the global healthcare sector, according to a report by IHS Markit. The faster connection could propel current trends, serving to provide faster and more reliable connectivity backbone to support the Internet of Medical Things, the transmission of wearable data, and even evolving technologies such as remote robotic surgery. Ultimately, 5G could offer the ability to provide more personalized care to patients, according to a Qualcomm report.
Imaging tests are the first and least invasive option for diagnosis. Read the blog written by the Mesothelioma Cancer Alliance to learn how diagnostic imaging and early detection can help lead to better outcomes.
Check back next Friday for a new issue of Diagnostic Reading. And don’t miss a future issue – subscribe today to have new blogs from Everything Rad delivered to your inbox!
#HealthcareIT #Radiology #Diagnosticreading #EverythingRad